PMC9362148_01
The spectrum of P. phragmitetus analyzed by MALDI Biotyper 3.1 (Bruker Daltonik GmbH, Germany).
fcimb-12-926154-g001.jpg
PMC9362148_01_fcimb-12-926154-g001.jpg
f1
P. phragmitetus (Figure 1) was identified by matrix-assisted laser desorption ionization/time of flight mass spectrometry (LVD MALDI Biotyper System, Bruker Daltonik GmbH, Germany). P. phragmitetus was also verified by DNA sequencing (Supplementary Figure 1 and Data Sheet 1), using bacterial 16S rDNA primers (forward primer: 5'-AGTTTGATCMTGGCTCAG-3', reverse primer: 5'-GGTTACCTTGTTACGACTT-3').
The patient's medical timeline.
fcimb-12-926154-g002.jpg
PMC9362148_01_fcimb-12-926154-g002.jpg
f2
The patient underwent regular hemodialysis at the local hospital and developed no fever in the following 3 months (the patient's medical timeline was shown in Figure 2).